MIRD Pamphlet No. 29: MIRDy90-A <sup>90</sup>Y Research Microsphere Dosimetry Tool. [PDF]
Marquis H +6 more
europepmc +1 more source
Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma. [PDF]
Williams AO +3 more
europepmc +1 more source
Yttrium-90 radiation segmentectomy of oligometastatic urothelial carcinoma. [PDF]
Warfield AE +5 more
europepmc +1 more source
Technical Note: Impact of impurities on Yttrium-90 glass microsphere activity quantitation. [PDF]
Beattie BJ, Kirov AS, Kesner AL.
europepmc +1 more source
<sup>177</sup>Lu-labeled amidoxime-functionalized biodegradable microspheres for transarterial radioembolization of hepatocellular carcinoma. [PDF]
Liu X +7 more
europepmc +1 more source
Extrahepatic <sup>90</sup>Y Complication; Gastric Ulcer Secondary to <sup>90</sup>Y Therapy for Liver Metastasis Despite Negative Preprocedural Imaging. [PDF]
Shea C +7 more
europepmc +1 more source
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas. [PDF]
Grassi I +15 more
europepmc +1 more source
High-Dose Transarterial Radioembolization of Hepatic Metastases Using Yttrium-90 Resin Microspheres. [PDF]
Schneider CCI +10 more
europepmc +1 more source
Impact of Injection Technique on Microsphere Distribution During Transarterial Radioembolization in a Successively Bifurcating In Vitro Model. [PDF]
Snoeijink TJ +6 more
europepmc +1 more source
Post-hoc analysis of adverse events during the EPOCH trial: reconsidering dosimetry. [PDF]
Lam M +6 more
europepmc +1 more source

